SB 683 - Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests - Pennsylvania Key Vote
Stephen Kinsey voted Yea (Passage With Amendment) on this Legislation.
Timeline
- Executive Signed
- Dec. 14, 2023
- Senate Concurrence Vote Passed
- Dec. 13, 2023
- House Bill Passed
- Dec. 13, 2023
- Senate Bill Passed
- June 28, 2023
- Introduced
- June 20, 2023
Related Issues
Stage Details
Title: Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests
Signed by Governor Josh Shapiro
Title: Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests
Title: Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests
Vote Smart's Synopsis:
Vote to amend and pass a bill that requires fentanyl and xylazine screening be included in many diagnostic urine tests.
Highlights:
-
Requires fentanyl and xylazine screening be included in many diagnostic urine tests Sec. 1).
-
Specifies that the provisions of this bill shall take effect 60 days after passage and approval by the governor (Sec. 2).
Title: Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests
Title: Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests